Company Filing History:

9 out of 1,627

New York University

where one patent can have more than one assignee

Years Active: 2003-2014

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8802660 - De novo synthesis of glucocorticoids in the epidermis and its uses and applications (2014-08-12),

2. 8394811 - Hydrazide compounds as thyroid hormone receptor modulators and uses thereof (2013-03-12),

3. 8124581 - Methods for treating breast cancer using NRIF3 related molecules (2012-02-28),

4. 7932362 - Antibodies to NRIF3 proteins (2011-04-26),

5. 7772202 - Methods for treating breast cancer using NRIF3 related molecules (2010-08-10),

6. 7563868 - NRIF3, a novel co-activator for nuclear hormone receptors (2009-07-21),

7. 7312066 - Nucleic acid molecules encoding NRC interacting factor-1 (NIF-1) (2007-12-25),

8. 7052843 - Transcription-based assay for identification of post-translational modification and its application in proteomics (2006-05-30),

9. 6639064 - NRIF3, novel co-activator for nuclear hormone receptors (2003-10-28),

Title: Herbert H Samuels: Innovator in Glucocorticoid Synthesis and Thyroid Modulation

Introduction

Herbert H Samuels is a notable inventor based in New Rochelle, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of glucocorticoids and thyroid hormone modulation. With a total of 9 patents to his name, his work has implications for various medical conditions.

Latest Patents

Samuels' latest patents include groundbreaking inventions such as "De novo synthesis of glucocorticoids in the epidermis and its uses and applications." This invention focuses on methods and compositions that can control glucocorticoid production in the skin, offering potential treatments for skin conditions like inflammation, chronic wounds, and certain cancers. Another significant patent is "Hydrazide compounds as thyroid hormone receptor modulators and uses thereof." This patent outlines a method for identifying compounds that modulate thyroid hormone activity, which can be crucial for treating conditions like hyperthyroidism.

Career Highlights

Throughout his career, Samuels has worked with prestigious institutions, including New York University and Molsoft LLC. His research has led to advancements in understanding and treating various health issues related to skin and thyroid hormone activity.

Collaborations

Samuels has collaborated with notable professionals in his field, including Dangsheng Li and Vandana Yajnik. These collaborations have further enriched his research and contributed to his innovative patents.

Conclusion

Herbert H Samuels stands out as a significant figure in the realm of pharmaceutical innovation. His contributions to glucocorticoid synthesis and thyroid hormone modulation continue to impact medical science and patient care.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com